More attention needs to be paid to patients who are at the verge of risk.
Those of us who work to improve patient care every day are focusing on a long-term question: How do we ensure that the system we are re-creating is as intelligent, efficient and effective as possible-especially as Medicaid covers more and more people?
To get at some answers, here are a few case-study glimpses into today’s real world:
Because these patients also participated in a voluntary program, offered through their insurers, in which a “care manager” helped them to create individualized plans, they received the information, medication and coordinated services they needed to resolve their specific issues and get on a path toward better-and ultimately less-costly-long-term health.
Most Americans need help navigating their healthcare, however. That has always been a concern, and it could become a far bigger one as the number who likely will be covered by Medicaid programs burgeons.
What can we learn from the case studies above to inform best practices as the healthcare industry proceeds into the next chapter of its history? Here are just a few lessons to consider:
First, far more attention needs to be paid to patients who are “at the verge of risk.” Currently, Americans who are at high risk medically get the most attention, utilize the most resources, and are integral to driving up costs. We need to prevent this population from growing-and that means better-serving the millions of people like the three described above, those who will become high-risk unless we act methodically to help them.
Meghan Harris is chief operating officer of KEPRO, a quality improvement and care management organization.
This week on Tuning Into The C-Suite Briana Contreras spoke with Dr. Scott Hayworth, president and CEO of New York-based CareMount Medical. In this interview, the two discussed the importance of patients staying in contact with their doctors for the sake of reducing public health risks and to discuss ongoing care options with them.
Listen
Eric Levin talks PBMs and how Scripta is Tackling the Market's Challenges for Patients
July 22nd 2020MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.
Listen